"Performance" VISEN PHARMA's half-year loss expands to 118 million RMB, no dividend declared
VISEN PHARMA-B (02561.HK) announced its interim results for the period ending June this year, with other income of RMB 5.301 million, a year-on-year decrease of 26.9%. Losses widened to RMB 118 million, compared to a loss of RMB 83.471 million in the same period last year; loss per share is RMB 1.18. No dividend is declared
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments